Fasting-mimicking diet and hormone therapy induce breast cancer regression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fasting-mimicking diet and hormone therapy induce breast cancer regression
Authors
Keywords
-
Journal
NATURE
Volume 583, Issue 7817, Pages 620-624
Publisher
Springer Science and Business Media LLC
Online
2020-07-16
DOI
10.1038/s41586-020-2502-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obesity and Breast Cancer: Role of Leptin
- (2019) Flora Sánchez-Jiménez et al. Frontiers in Oncology
- A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
- (2018) Norman Sachs et al. CELL
- Overcoming endocrine resistance in hormone receptor–positive breast cancer
- (2018) A. AlFakeeh et al. Current Oncology
- Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor–positive Breast Cancer
- (2018) Chrysiis Michaloglou et al. MOLECULAR CANCER THERAPEUTICS
- Muscle mass estimation on breast magnetic resonance imaging in breast cancer patients: comparison between psoas muscle area on computer tomography and pectoralis muscle area on MRI
- (2018) Federica Rossi et al. EUROPEAN RADIOLOGY
- Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
- (2018) Benjamin D. Hopkins et al. NATURE
- Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease
- (2017) Min Wei et al. Science Translational Medicine
- Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer
- (2017) Kazuhiro Araki et al. Breast Cancer
- CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
- (2017) Smruthi Vijayaraghavan et al. Nature Communications
- EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer
- (2017) Ayesha N. Shajahan-Haq et al. Oncotarget
- Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy
- (2017) Stefano Di Biase et al. PLOS BIOLOGY
- Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity
- (2016) Stefano Di Biase et al. CANCER CELL
- A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line
- (2016) Annette Lasham et al. INTERNATIONAL JOURNAL OF CANCER
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- (2016) Massimo Cristofanilli et al. LANCET ONCOLOGY
- Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ
- (2016) Ameet K. Mishra et al. Oncotarget
- A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan
- (2015) Sebastian Brandhorst et al. Cell Metabolism
- The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients—a comprehensive review
- (2015) O Grundmann et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
- (2015) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular mechanisms of tamoxifen-associated endometrial cancer (Review)
- (2015) RONG HU et al. Oncology Letters
- Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition
- (2015) Irene Caffa et al. Oncotarget
- Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells
- (2014) Simon A. Hawley et al. BIOCHEMICAL JOURNAL
- Protein Blend Ingestion Following Resistance Exercise Promotes Human Muscle Protein Synthesis
- (2013) Paul T. Reidy et al. JOURNAL OF NUTRITION
- Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
- (2013) Gianpiero Di Leva et al. PLoS Genetics
- Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer
- (2011) Hirokuni Ikeda et al. CANCER SCIENCE
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced Levels of IGF-I Mediate Differential Protection of Normal and Cancer Cells in Response to Fasting and Improve Chemotherapeutic Index
- (2010) C. Lee et al. CANCER RESEARCH
- Molecular mechanisms of leptin and adiponectin in breast cancer
- (2010) Thierry Jardé et al. EUROPEAN JOURNAL OF CANCER
- The Coordinated P53 and Estrogen Receptor Cis-Regulation at an FLT1 Promoter SNP Is Specific to Genotoxic Stress and Estrogenic Compound
- (2010) Yari Ciribilli et al. PLoS One
- Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
- (2008) S. Massarweh et al. CANCER RESEARCH
- Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis
- (2008) Chad J. Creighton et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started